Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Czechia / NCT06672601
Starting soon Observational

Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients After Pancreatic Procedures.

NCT06672601 · tracked via the Priya Life Science Czechia tracker
Sponsor
Charles University, Czech Republic
Phase
Observational
Started
2025-01-01
Last updated
2024-11-08

Condition(s) studied

Intra Abdominal PressureAbdominal Compartment SyndromePancreatic SurgeryPancreatic Fistula After PancreaticoduodenectomyDelayed Gastric EmptyingAnastomotic LeaksOverload Fluid

Study summary

This study investigates the development of intra-abdominal hypertension and compartment syndrome in patients undergoing elective pancreatic procedures. Main objective is to determine the proportion of patients after pancreatic operation who develop elevated intra-abdominal pressure and assess its association with postoperative complication rates. Another goal of the study is to compare open versus robotic pancreatic procedures regarding the occurrence of intra-abdominal hypertension and abdominal compartment syndrome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients ≥ 18-year-old * Indication for elective pancreatic procedure * Written informed consent Exclusion Criteria: * Patients \<18 years old. * Contraindication for urinary catheter placement. * Refusal to participate in the study.

Primary outcome measure(s)

  • Prevalence of Intra-abdominal hypertension and abdominal compartment syndrome — From the admission to the intensive care unit until the postoperative day 7 or until discharge from the ICU
    Prevalence of intra-abdominal hypertension and abdominal compartment syndrome in patients following pancreatic procedures.

Trial sites (1)

FacilityCityRegionStatus
Department of Surgery 2nd Faculty of Medicine, Charles University and Military University Hospital Prague Prague Prague 6

More Charles University, Czech Republic trials in Czechia

Immune Homeostasis in Sepsis and Septic Shock Recruiting
Exercise-Based Strategies for Chronic Back Pain Starting soon
Detection of Muscle Quality in Children - Protocol for a Validation Study Starting soon
PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery Active, not recruiting
Single-center Evaluation of Human Milk Quantity and Quality Over Five Years Recruiting

Other trials for the same condition

PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06672601 on ClinicalTrials.gov ↗ ← All trials in Czechia